- Home
- VCEL
VCEL
Vericel Corporation
as 11-15-2024 4:00pm EST
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | N/A | IPO Year: | 1997 |
| Target Price: | $57.83 | AVG Volume (30 days): | 444.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $32.31 - $57.81 | Next Earning Date: | 11-07-2024 |
| Revenue: | $226,844,000 | Revenue Growth: | 22.48% |
| Revenue Growth (this year): | 23.78% | Revenue Growth (next year): | 23.37% |
Stock Insider Trading Activity of Vericel Corporation (VCEL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ZERBE ROBERT L MD | VCEL | Director | Nov 11 '24 | Sell | $56.25 | 5,000 | $281,250.00 | 26,595 | |
| Colangelo Dominick | VCEL | President and CEO | Oct 16 '24 | Sell | $40.86 | 35,000 | $1,430,100.00 | 220,937 | |
| GILMAN STEVEN C | VCEL | Director | Oct 16 '24 | Sell | $41.36 | 5,833 | $241,252.88 | 11,000 | |
| GILMAN STEVEN C | VCEL | Director | Oct 2 '24 | Sell | $40.35 | 5,833 | $235,361.55 | 11,000 | |
| SIEGAL JONATHAN | VCEL | Principal Accounting Officer | Sep 30 '24 | Sell | $41.90 | 568 | $23,799.20 | 1,124 | |
| GILMAN STEVEN C | VCEL | Director | Sep 18 '24 | Sell | $45.54 | 5,834 | $265,680.36 | 11,000 | |
| Colangelo Dominick | VCEL | President and CEO | Sep 11 '24 | Sell | $43.64 | 35,000 | $1,527,225.00 | 220,937 | |
| GILMAN STEVEN C | VCEL | Director | Sep 4 '24 | Sell | $48.58 | 5,000 | $242,900.00 | 11,000 | |
| Hopper Jonathan Mark | VCEL | Chief Medical Officer | Sep 3 '24 | Sell | $49.83 | 10,000 | $498,300.00 | 58,229 |
Latest Vericel Corporation News
VCEL Breaking Stock News: Dive into VCEL Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
High Growth Tech Stocks To Explore In November 2024
Argus Research
5 days ago
VCEL: Raising target price to $59.00
Investor's Business Daily
6 days ago
Vericel Stock Sees RS Rating Shoot Higher
MT Newswires
6 days ago
Truist Securities Raises Price Target on Vericel to $61 From $57, Maintains Buy Rating
Simply Wall St.
8 days ago
Vericel Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
9 days ago
Vericel Corp (VCEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic FDA ...
MT Newswires
10 days ago
Vericel's Q3 Net Loss Narrows, Revenue Increases
Zacks
10 days ago
Vericel Corporation (VCEL) Reports Q3 Loss, Tops Revenue Estimates
Compare VCEL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VCEL Vericel Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.